Doris Apt
6Patents
4h-index
4Co-inventors
46Inventor score
Filing activity: Oct 27, 1998 → Mar 11, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8715694B2 | Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein | Emerging Cross-Sectional Technologies | 50 | Active |
| US6399383B1 | Human papilloma virus vectors | Chemistry; Metallurgy | 34 | Expired |
| US7476390B2 | Flavivirus antigens | Emerging Cross-Sectional Technologies | 5 | Expired |
| US8158131B2 | Recombinant dengue virus antigens comprising the C15 signal peptide, full-length PRM protein, and full-length E protein | Emerging Cross-Sectional Technologies | 4 | Active |
| US8168772B2 | Nucleic acids encoding novel chimeric C15/prM/E dengue virus immunogens prepared by DNA shuffling | Emerging Cross-Sectional Technologies | 2 | Active |
| US9186397B2 | Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.